Stratification Analysis and Case-control Study of Relationships between Interleukin-6 Gene Polymorphisms and Cervical Cancer Risk in a Chinese Population |
Shi, Wen-Jing
(Department of Clinical Laboratory, International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai Jiaotong University School of Medicine)
Liu, Hao (Department of Health Technology and Informatics, The Hong Kong Polytechnic University) Wu, Dan (Department of Obstetrics and Gynecology, International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai Jiaotong University School of Medicine) Tang, Zhen-Hua (Department of Clinical Laboratory, International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai Jiaotong University School of Medicine) Shen, Yu-Chen (Department of Clinical Laboratory, International Peace Maternity and Child Health Hospital of China Welfare Institute, Shanghai Jiaotong University School of Medicine) Guo, Lin (Department of Clinical Laboratory, Fudan University Shanghai Cancer Center, Shanghai Medical College of Fudan University) |
1 | Bennermo M, Held C, Green F, et al (2004). Prognostic value of plasma interleukin-6 concentrations and the -174 G>C and -572 G>C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis. Atherosclerosis, 174, 157-63. DOI |
2 | Bowcock AM, Kidd JR, Lathrop GM, et al (1988). The human “interferon-beta 2/hepatocyte stimulating factor/interleukin-6” gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics, 3, 8-16. DOI |
3 | Castro FA, Haimila K, Sareneva I, et al (2009). Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population-a candidate gene approach. Int J Cancer, 125, 1851-8. DOI ScienceOn |
4 | Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC (2013). Human papillomavirus and cervical cancer. Lancet, 382, 889-99. DOI |
5 | Fishman D, Faulds G, Jeffery R, et al (1998). The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest, 102, 1369-76. DOI ScienceOn |
6 | Gangwar R, Mittal B, Mittal RD (2009). Association of interleukin-6 -174G>C promoter polymorphism with risk of cervical cancer. Int J Biol Markers, 24, 11-6. |
7 | Grimm C, Six L, Tomovski C, et al (2005). A common interleukin-6 promoter polymorphism in patients with vulvar cancer. J Soc Gynecol Investig, 12, 617-20. DOI |
8 | Grimm C, Watrowski R, Baumuhlner K, et al (2011). Genetic variations of interleukin-1 and -6 genes and risk of cervical intraepithelial neoplasia. Gynecol Oncol, 121, 537-41. DOI |
9 | Hamaguchi M, Kawahito Y, Ishino H, et al (2011). Mucin from rheumatoid arthritis synovial fluid enhances interleukin-6 production by human peripheral blood mononuclear cells. Hum Immunol, 72, 241-8. DOI |
10 | Huang D, Zheng C, Giscombe R, et al (1999). Polymorphisms at -174 and in the 3' flanking region of interleukin-6 (IL-6) gene in patients with myasthenia gravis. J Neuroimmunol, 101, 197-200. DOI |
11 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
12 | Kyo S, Kanaya T, Takakura M, Inoue M (2000). A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and IL-6. Gynecol Oncol, 78, 383-7. DOI ScienceOn |
13 | Landi S, Moreno V, Gioia-Patricola L, et al (2003). Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res, 63, 3560-6. |
14 | Liu D, Zhou P, Zhang L, et al (2011). Differential expression of oct4 in hpv-positive and hpv-negative cervical cancer cells is not regulated by DNA methyltransferase 3a. Tumour Biol, 32, 941-50. DOI |
15 | Ma Y, Tang RK, Yang X, et al (2011). Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis. Hum Immunol, 72, 641-51. DOI |
16 | Magalhaes JF, Cortinhas AJ, Albuquerque CM, et al (2013). Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk. Mol Biol Rep, 40, 449-55. DOI |
17 | Shi TY, Zhu ML, He J, et al (2013). Polymorphisms of the interleukin 6 gene contribute to cervical cancer susceptibility in eastern Chinese women. Hum Genet, 132, 301-12. DOI |
18 | Mosaad YM, Fathy H, Fawzy Z, El-Saied MA (2012). Tumor necrosis factor-α -308 G>A and interleukin-6 -174 G>C promoter polymorphisms and pemphigus. Hum Immunol, 73, 560-5. DOI |
19 | Ni J, Ye Y, Teng F, Wu Q (2013). Interleukin 10 polymorphisms and cervical cancer risk: a meta-analysis. Int J Gynecol Cancer, 23, 126-33. DOI ScienceOn |
20 | Nogueira de Souza NC, Brenna SM, Campos F, et al (2006). Interleukin-6 polymorphisms and the risk of cervical cancer. Int J Gynecol Cancer, 16, 1278-82. DOI |
21 | Shuai HL, Luo X, Yan RL, Li J, Chen DL (2012). XRCC1 polymorphisms are associated with cervical cancer risk and response to chemotherapy: a systematic review and metaanalysis. Asian Pac J Cancer Prev, 13, 6423-7. DOI |
22 | Slattery ML, Curtin K, Sweeney C, Wolff RK, Baumgartner RN, Baumgartner KB, Giuliano AR, Byers T (2008). Modifying effects of IL-6 polymorphisms on body size-associated breast cancer risk. Obesity, 16, 339-47. DOI |
23 | Srivani R, Nagarajan B (2003). A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer. Int J Gynecol Cancer, 13, 331-9. DOI |
24 | Tao QS, Huang HL, Chai Y, et al (2012). Interleukin-6 upregulates the expression of interleukin-15 is associated with MAPKs and PI3-K signaling pathways in the human keratinocyte cell line, HaCaT. Mol Biol Rep, 39, 4201-5. DOI |
25 | Upadhyay R, Jain M, Kumar S, Ghoshal UC, Mittal B (2008). Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study. Clin Immunol, 128, 199-204. DOI |
26 | Xu B, Niu XB, Wang ZD, et al (2011). IL-6 -174G>C polymorphism and cancer risk: a meta-analysis involving 29, 377 cases and 37, 739 controls. Mol Biol Rep, 38, 2589-96. DOI |
27 | Vairaktaris E, Yiannopoulos A, Vylliotis A, et al (2006). Strong association of interleukin-6 -174 G>C promoter polymorphism with increased risk of oral cancer. Int J Biol Markers, 21, 246-50. |
28 | Wei LH, Kuo ML, Chen CA, et al (2001a). Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol, 82, 49-56. DOI ScienceOn |
29 | Wei LH, Kuo ML, Chen CA, et al (2001b). The anti-apoptotic role of interleukin-6 in human cervical cancer is mediated by up-regulation of Mcl-1 through a PI 3-K/Akt pathway. Oncogene, 20, 5799-809. DOI ScienceOn |
30 | Yang S, Jia C, Zhu H, Han S (2012). CYP1A1 Ile462Val polymorphism and cervical cancer: evidence from a metaanalysis. Tumour Biol, 33, 2265-72. DOI |
31 | Zhang H, Xu Y, Li L, Liu R, Ma B (2012). The interleukin-6-174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis. Urol Int, 88, 447-53. DOI ScienceOn |
32 | Zhang HL, Zhang YJ (2013). A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer. Tumor Biol, 34, 1659-65. DOI |
33 | Zhang ZY, Jin XY, Wu R, et al (2012). Meta-analysis of the association between GSTM1 and GSTT1 gene polymorphisms and cervical cancer. Asian Pac J Cancer Prev, 13, 815-9. 과학기술학회마을 DOI |
34 | Zhou X, Gu Y, Zhang SL (2012). Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev, 13, 4909-14. 과학기술학회마을 DOI ScienceOn |
35 | Tjiong MY, van der Vange N, ten Kate FJ, et al (1999). Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol Oncol, 73, 285-91. DOI ScienceOn |
36 | Zhu J, Wu L, Kohlmeier M, Ye F, Cai W (2013). Association between MTHFR C677T, MTHFR A1298C and MS A2756G polymorphisms and risk of cervical intraepithelial neoplasia II/III and cervical cancer: a meta-analysis. Mol Med Rep, 8, 919-27. |
37 | Barbisan G, Perez LO, Contreras A, Golijow CD (2012). TNF- and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol, 33, 1549-56. DOI |